| 000 | 01426 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250514162453.0 | ||
| 264 | 0 | _c20040331 | |
| 008 | 200403s 0 0 chi d | ||
| 022 | _a1000-2588 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMeng, Fan-yi | |
| 245 | 0 | 0 |
_a[STI 571 for treating 19 patients with chronic-phase chronic myeloid leukemia]. _h[electronic resource] |
| 260 |
_bDi 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA _cNov 2003 |
||
| 300 |
_a1149-50 p. _bdigital |
||
| 500 | _aPublication Type: English Abstract; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBenzamides |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImatinib Mesylate |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xblood |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Chronic-Phase _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPiperazines _xadverse effects |
| 650 | 0 | 4 |
_aPyrimidines _xadverse effects |
| 700 | 1 | _aZheng, Wei-yang | |
| 700 | 1 | _aLiu, Xiao-li | |
| 700 | 1 | _aXu, Bing | |
| 700 | 1 | _aSong, Lan-lin | |
| 700 | 1 | _aZhang, Yu | |
| 700 | 1 | _aHuang, Fen | |
| 773 | 0 |
_tDi 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA _gvol. 23 _gno. 11 _gp. 1149-50 |
|
| 999 |
_c14361866 _d14361866 |
||